KEYS vs PRLD · P/E 57, rev $4.98B vs rev $6.5M
Keysight Technologies Inc (KEYS) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the KEYS and PRLD stock pages for the full models.
Not investment advice.